New At-Home Test Aids In Cancer Screening

There’s motivating news for the countless Americans at danger for colon cancer. A brand-new, user friendly fecal occult blood test (FOBT) is readily available for at-home screening and is developed particularly to discover colon cancer at its earliest phases.

Hemoccult ICT is a brand-new, budget-friendly and safe FOBT screening choice for colon cancer-the 2nd leading reason for cancer-related death in the United States. Regardless of its high occurrence, colon cancer is an extremely treatable cancer, with a 90 percent survival rate when discovered early. Just half of the more than 80 million Americans over age 50 have actually been evaluated for colon cancer.

The American Cancer Society advises yearly screening with a FOBT for both ladies and males starting at age 50. When compared with no screening, yearly colon cancer screening with FOBT has actually been shown to reduce death by 33 percent. It is crucial to start evaluating prior to establishing signs since colon cancer can take 3 to 10 years or longer to establish in the typical client.

FOBT vs. Colonoscopy

For years colonoscopy has actually been the most widely known test in colon cancer screening. • Due to a restricted number of experienced specialists and the devices required to carry out the tests, the optimum number of colonoscopies that can be carried out in the United States each year can accommodate just a quarter of the Americans in requirement of screening.

Unlike other offered FOBTs, the brand-new Hemoccult ICT has no drug or dietary restrictions-allowing individuals to start checking at their benefit. A follow-up colonoscopy usually is advised if a test comes back favorable.

Regardless of its high occurrence, colon cancer is an extremely treatable cancer, with a 90 percent survival rate when discovered early. Yearly colon cancer screening with FOBT has actually been shown to reduce death by 33 percent when compared with no screening. For years colonoscopy has actually been the most widely known test in colon cancer screening.